drugset / Trial / NCT05538767

Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm

NCT05538767

RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare the efficacy and safety of emodepside to that of albendazole (Zentel®) in participants aged 12-60, inclusive, infected with hookworm.

Timeline

Start
2022-09-16
Primary completion
2023-04-11
Completion
2023-04-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Albendazole Small molecule 400 mg
Subject Emodepside Small molecule 30 mg